Effects and Mechanisms of Tacrolimus on Development of Murine Th17 Cells

被引:6
作者
Zhang, X. -J. [1 ]
Kang, Y. -D. [1 ]
Xiao, L. [1 ]
Li, R. -D. [1 ]
Ding, G. -S. [1 ]
Wang, Z. -X. [1 ]
Fu, Z. -R. [1 ]
机构
[1] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Organ Transplantat, Shanghai 200003, Peoples R China
关键词
T-CELLS; ALLOGRAFT-REJECTION; DIFFERENTIATION; GENERATION; INJURY; IL-17; RESPONSES; PROMOTES; T(H)17; LONG;
D O I
10.1016/j.transproceed.2010.08.033
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tacrolimus (Tac, FK506) is a widely used T-cell-targeted immunosuppression drug known as a calcineurin inhibitor. However, its pharmacologic effects on T-helper type 17 (Th17) cells have not been fully elucidated. Herein, we demonstrate that Tac inhibits Th17 cell differentiation and proliferation, and expression of IL-17 messenger RNA. The proposed mechanism is that Tac inhibits calcineurin and T-cell receptor stimulation-induced cell division. Because Th17 cells participate in allograft rejection, the results of the present study suggest a novel model of immunosuppression effects of Tac. In addition, they provide further implications for the therapeutic immunosuppression effects of Tac on allograft rejection.
引用
收藏
页码:3779 / 3783
页数:5
相关论文
共 20 条
  • [1] Antonysamy MA, 1999, J IMMUNOL, V162, P577
  • [2] Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function
    Basile, DP
    Donohoe, D
    Roethe, K
    Osborn, JL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2001, 281 (05) : F887 - F899
  • [3] Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
    Bettelli, E
    Carrier, YJ
    Gao, WD
    Korn, T
    Strom, TB
    Oukka, M
    Weiner, HL
    Kuchroo, VK
    [J]. NATURE, 2006, 441 (7090) : 235 - 238
  • [4] Cyclosporine A inhibits IL-15-induced IL-17 production in CD4+ T cells via down-regulation of PI3K/Akt and NF-κB
    Cho, Mi-La
    Ju, Ji Hyeon
    Kim, Kyoung-Woon
    Moon, Young-Mee
    Lee, Seon-Yeong
    Min, So-Youn
    Cho, Young-Gyu
    Kim, Hyun-Sook
    Park, Kyung-Su
    Yoon, Chong-Hyeon
    Lee, Sang Heon
    Park, Sung-Hwan
    Kim, Ho-Youn
    [J]. IMMUNOLOGY LETTERS, 2007, 108 (01) : 88 - 96
  • [5] Induction of TH1 and TH2 CD4+ T cell responses: The alternative approaches
    Constant, SL
    Bottomly, K
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 297 - 322
  • [6] Differential Expression of Interleukin-17A and-17F Is Coupled to T Cell Receptor Signaling via Inducible T Cell Kinase
    Gomez-Rodriguez, Julio
    Sahu, Nisebita
    Handon, Robin
    Davidson, Todd S.
    Anderson, Stacie M.
    Kirby, Martha R.
    August, Avery
    Schwartzberg, Pamela L.
    [J]. IMMUNITY, 2009, 31 (04) : 587 - 597
  • [7] Manipulating immune responses with immunosuppressive agents that target NFAT
    Kiani, A
    Rao, A
    Aramburu, J
    [J]. IMMUNITY, 2000, 12 (04) : 359 - 372
  • [8] Maladaptive role of IL-6 in ischemic acute renal failure
    Kielar, ML
    John, R
    Bennett, M
    Richardson, JA
    Shelton, JM
    Chen, LY
    Jeyarajah, DR
    Zhou, XJ
    Zhou, H
    Chiquett, B
    Nagami, GT
    Lu, CY
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (11): : 3315 - 3325
  • [9] Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+T regulatory cells
    Kopf, Heather
    De la Rosa, Gonzalo M.
    Howard, O. M. Zack
    Chen, Xin
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2007, 7 (13) : 1819 - 1824
  • [10] Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation
    Laurence, Arian
    Tato, Cristina M.
    Davidson, Todd S.
    Kanno, Yuka
    Chen, Zhi
    Yao, Zhengju
    Blank, Rebecca B.
    Meylan, Francoise
    Siegel, Richard
    Hennighausen, Lothar
    Shevach, Ethan M.
    O'Shea, John J.
    [J]. IMMUNITY, 2007, 26 (03) : 371 - 381